First Eagle Investment Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-8,414
| Closed | -$214K | – | 138 |
|
|
2019
Q2 | $214K | Hold |
8,414
| – | – | ﹤0.01% | 141 |
|
|
2019
Q1 | $358K | Hold |
8,414
| – | – | ﹤0.01% | 145 |
|
|
2018
Q4 | $122K | Sell |
8,414
-714
| -8% | -$10.4K | ﹤0.01% | 158 |
|
|
2018
Q3 | $639K | Hold |
9,128
| – | – | ﹤0.01% | 154 |
|
|
2018
Q2 | $677K | Hold |
9,128
| – | – | ﹤0.01% | 155 |
|
|
2018
Q1 | $869K | Hold |
9,128
| – | – | ﹤0.01% | 153 |
|
|
2017
Q4 | $1.18M | Hold |
9,128
| – | – | ﹤0.01% | 214 |
|
|
2017
Q3 | $620K | Hold |
9,128
| – | – | ﹤0.01% | 251 |
|
|
2017
Q2 | $863K | Hold |
9,128
| – | – | ﹤0.01% | 221 |
|
|
2017
Q1 | $1.31M | Sell |
9,128
-7,301
| -44% | -$1.05M | ﹤0.01% | 210 |
|
|
2016
Q4 | $2.08M | Buy |
16,429
+9,286
| +130% | +$1.18M | 0.01% | 199 |
|
|
2016
Q3 | $1.09M | Hold |
7,143
| – | – | ﹤0.01% | 239 |
|
|
2016
Q2 | $822K | Buy |
+7,143
| New | +$822K | ﹤0.01% | 256 |
|
|
2015
Q2 | – | Sell |
-2,800
| Closed | -$1.44M | – | 326 |
|
|
2015
Q1 | $1.44M | Sell |
2,800
-3,935
| -58% | -$2.03M | ﹤0.01% | 218 |
|
|
2014
Q4 | $3.61M | Buy |
+6,735
| New | +$3.61M | 0.01% | 189 |
|
|
2014
Q3 | – | Sell |
-952
| Closed | -$1.3M | – | 350 |
|
|
2014
Q2 | $1.3M | Sell |
952
-94
| -9% | -$129K | ﹤0.01% | 224 |
|
|
2014
Q1 | $1.45M | Sell |
1,046
-97
| -8% | -$135K | ﹤0.01% | 194 |
|
|
2013
Q4 | $1.14M | Buy |
1,143
+191
| +20% | +$190K | ﹤0.01% | 203 |
|
|
2013
Q3 | $992K | Buy |
+952
| New | +$992K | ﹤0.01% | 218 |
|